Panacea Biotec Ltd (PANACEABIO)
₹135.82▲1.22%
Performance
Day's Low
Day's High
₹133.82₹136.2852 Week's Low
52 Week's High
₹112.35₹202.5
| Returns % | |
| 1 Month Return | + 0.66 % |
| 3 Month Return | -5.47 % |
| 1 Year Return | + 9.27 % |
| Market Stats | |
| Previous Close | ₹134.18 |
| Open | ₹134.19 |
| Volume | 55.34K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹821.86Cr |
Key Statistics
| P/E Ratio | -838.62 |
| PEG Ratio | -157.64 |
| Market Cap | ₹821.86 Cr |
| P/B Ratio | 2.18 |
| EPS | 5.64204654917755 |
Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹821.86 Cr | 2.07% | 0.64 | -₹34 Cr | ₹459 Cr |
 | NA | ₹9.89 Cr | 13.6% | 5.69 | NA | NA |
| NA | ₹56.15 Cr | -4.65% | 0.59 | NA | NA |
 | BUY | ₹2,944.76 Cr | 20.99% | 0.63 | ₹142 Cr | ₹1,668 Cr |
| NA | ₹32.62 Cr | 13.59% | 0.53 | NA | NA |
Company Information
Share Price: ₹135.82 per share as on 24 Jul, 2024 04:01 PM
Market Capitalisation: ₹821.86Cr as of today
Revenue: ₹136.46Cr as on March 2024 (Q1 24)
Net Profit: ₹-1.99Cr as on March 2024 (Q1 24)
Listing date: 18 Apr, 1996
Chairperson Name: Rajesh Jain
| Organisation | Panacea Biotec Ltd |
| Headquarters | New Delhi |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Panacea Biotec Ltd
Panacea Biotec Reports 5.84% YoY Increase in Net Sales - 14 Jun, 2024
Panacea Biotec's consolidated net sales for March 2024 stood at Rs. 136.46 crore, up by 5.84% YoY. However, the company reported a quarterly net loss of Rs. 1.43 crore in March 2024, an increase of 88.72% from the same period last year. The stock has given negative returns of -19.95% over the last six months and -3.11% over the last twelve months.
Panacea Biotec's Net Cash Position Increases to INR 1.59 Billion - 05 Jun, 2024
Panacea Biotec had a net cash position of INR 1.59 billion as of March 2024, with liabilities outweighing the sum of its cash and receivables by INR 1.62 billion. The company reported revenue growth of 27% over the past year and may be on a path to profitability.
Panacea Biotec Q4 Results Show Loss Decrease and Revenue Decline - 02 Jun, 2024
Panacea Biotec's Q4 results show a 5.84% increase in topline, with the loss decreasing by 88.47% YoY. However, revenue declined by 9.33%, and the company delivered -2.71% return in the last week.
Panacea Biotec Reports Net Loss of Rs 1.99 Crore in Q4 - 30 May, 2024
Panacea Biotec reported a consolidated net loss of Rs 1.99 crore in the March 2024 quarter, with sales rising by 5.84% to Rs 136.46 crore. However, for the full year ended March 2024, the company's net loss reduced to Rs 1.50 crore from Rs 33.75 crore in the previous year, while sales rose by 21.57% to Rs 559.17 crore.
Insights on Panacea Biotec Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, -8.29 Cr → -1.99 Cr (in ₹), with an average increase of 143.7% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.26% to 0.27% in Mar 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 77.9%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 73.59% of holdings in Mar 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.7% return, outperforming this stock by 187.7%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 158.96 Cr → 150.01 Cr (in ₹), with an average decrease of 5.6% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 25.46% to 25.30% in Mar 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 years, PANACEABIO stock has moved down by -60.0%
Company Financials
| Q'1 24 | Q/Q Change | |
|---|---|---|
Revenue | ₹136.46Cr | ↓9.33% |
Net Income | -₹1.99Cr | ↓9.55% |
Net Profit Margin | -1.46% | - |
| 2023 | Y/Y Change | |
|---|---|---|
Revenue | ₹459.95Cr | ↓30.44% |
Net Income | -₹33.75Cr | ↓103.13% |
Net Profit Margin | -7.34% | ↓104.50% |
| 2023 | Y/Y Change | |
|---|---|---|
Total Assets | ₹769.92Cr | ↓7.67% |
Total Liabilities | ₹444.27Cr | ↑6.08% |
| 2023 | Y/Y Change | |
|---|---|---|
Operating Cash Flow | -₹10.74Cr | ↓79.62% |
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 73.59% | 0.00 | |
| Foreign Institutions | 0.27% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 25.3% | 0.00 | |
| Others | 0.84% | 0.00 |
Key Indicators
Panacea Biotec Ltd Valuation
Panacea Biotec Ltd in the last 5 years
Lowest (-915.62x)
April 25, 2024
Today (-838.62x)
July 23, 2024
Industry (56.07x)
July 23, 2024
Highest (113.15x)
October 5, 2023
Earnings and Dividends
Panacea Biotec Ltd Earnings Results
Panacea Biotec Ltd’s net profit jumped 84.31% since last year same period to ₹-1.99Cr in the Q4 2023-2024. On a quarterly growth basis, Panacea Biotec Ltd has generated 9.55% jump in its net profits since last 3-months.
Read More about Earnings ResultsPanacea Biotec Ltd Dividends May,2011
In the quarter ending March 2011, Panacea Biotec Ltd has declared dividend of ₹0.75 - translating a dividend yield of 0.56%.
Read More about Dividends
Technicals Summary
Bearish
Neutral
Bullish
Panacea Biotec Ltd is currently in a Bearish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Panacea Biotec Ltd shares.
Panacea Biotec Ltd (PANACEABIO) share price today is ₹135.82
Panacea Biotec Ltd is listed on NSE
Panacea Biotec Ltd is listed on BSE
- Today’s highest price of Panacea Biotec Ltd is ₹136.28.
- Today’s lowest price of Panacea Biotec Ltd is ₹133.82.
PE Ratio of Panacea Biotec Ltd is -838.62
PE ratio = Panacea Biotec Ltd Market price per share / Panacea Biotec Ltd Earnings per share
Today’s traded volume of Panacea Biotec Ltd(PANACEABIO) is 55.34K.
Today’s market capitalisation of Panacea Biotec Ltd(PANACEABIO) is ₹821.86Cr.
| Panacea Biotec Ltd(PANACEABIO | Price |
|---|---|
52 Week High | ₹202.5 |
52 Week Low | ₹112.35 |
Panacea Biotec Ltd(PANACEABIO) share price is ₹135.82. It is down -32.93% from its 52 Week High price of ₹202.5
Panacea Biotec Ltd(PANACEABIO) share price is ₹135.82. It is up 20.89% from its 52 Week Low price of ₹112.35
| Panacea Biotec Ltd(PANACEABIO | Returns |
|---|---|
1 Day Returns | 1.64% |
1 Month Returns | 0.66% |
3 Month Returns | -5.47% |
1 Year Returns | 9.27% |